![](/wp-content/uploads/2023/02/Screenshot-2023-02-02-at-4.52.55-PM.png)
$599
Lilly, Merck, and Roche Q4 ’22 Earnings Updates
Three cardiometabolic-related news items have been observed: Lilly (press release; slides), Merck (press release; slides), and Roche (press release; slides) hosted their respective Q4 ’22 earnings calls. Below, FENIX provides highlights and insights from the earnings calls.